9 found
Order:
Disambiguations
Martin B. Delatycki [5]Martin Delatycki [4]
  1.  23
    ‘Is It Better Not to Know Certain Things?’: Views of Women Who Have Undergone Non-Invasive Prenatal Testing on its Possible Future Applications.Hilary Bowman-Smart, Julian Savulescu, Cara Mand, Christopher Gyngell, Mark D. Pertile, Sharon Lewis & Martin B. Delatycki - 2019 - Journal of Medical Ethics 45 (4):231-238.
    Non-invasive prenatal testing is at the forefront of prenatal screening. Current uses for NIPT include fetal sex determination and screening for chromosomal disorders such as trisomy 21. However, NIPT may be expanded to many different future applications. There are a potential host of ethical concerns around the expanding use of NIPT, as examined by the recent Nuffield Council report on the topic. It is important to examine what NIPT might be used for before these possibilities become consumer reality. There is (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  2.  71
    Predictive Genetic Testing in Minors for Late-Onset Conditions: A Chronological and Analytical Review of the Ethical Arguments: Figure 1.Cara Mand, Lynn Gillam, Martin B. Delatycki & Rony E. Duncan - 2012 - Journal of Medical Ethics 38 (9):519-524.
    Predictive genetic testing is now routinely offered to asymptomatic adults at risk for genetic disease. However, testing of minors at risk for adult-onset conditions, where no treatment or preventive intervention exists, has evoked greater controversy and inspired a debate spanning two decades. This review aims to provide a detailed longitudinal analysis and concludes by examining the debate's current status and prospects for the future. Fifty-three relevant theoretical papers published between 1990 and December 2010 were identified, and interpretative content analysis was (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  3.  11
    Predictive Testing in Minors: The Need for Empirical Evidence.Martin B. Delatycki, Cara Mand, Lynn Gillam & Rony Duncan - 2012 - Journal of Medical Ethics 38 (9):533-534.
  4.  3
    Should Third Party Consent to Research Be Mandated? Should There Be a Right for Third Parties to Have Data About Them Withdrawn From a Research Project? Two Perspectives.[Series of Two Articles]: Part 1.[Ethics Committee Reflection.]. [REVIEW]Martin Delatycki - 2004 - Monash Bioethics Review 23 (1):75.
    Direct download  
     
    Export citation  
     
    Bookmark  
  5. Sperm Donor Suffers Years Later From Inherited Disease.D. O. E. Gebhardt & Martin Delatycki - 2002 - Journal of Medical Ethics 28 (4):213-214.
    A case is described of a man who discovered years after donating sperm for artificial insemination, that he had a serious genetic disease, autosomal dominant cerebellar ataxia. This manifests itself only years after puberty and occurs in 50% of the progeny. The sperm had been used for the conception of 18 children in 13 women. The parents were only told three years after the insemination. This long time interval was unavoidable since many of the parents had to be found and (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
  6.  3
    Study Protocol: The Australian Genetics and Life Insurance Moratorium—Monitoring the Effectiveness and Response (A-GLIMMER) Project.Paul Lacaze, Louise Keogh, Margaret Otlowski, Ingrid Winship, Kristine Barlow-Stewart, Martin Delatycki, Penny Gleeson, Tiffany Boughtwood, Andrea Belcher, Aideen McInerney-Leo & Jane Tiller - 2021 - BMC Medical Ethics 22 (1):1-14.
    BackgroundThe use of genetic test results in risk-rated insurance is a significant concern internationally, with many countries banning or restricting the use of genetic test results in underwriting. In Australia, life insurers’ use of genetic test results is legal and self-regulated by the insurance industry ). In 2018, an Australian Parliamentary Inquiry recommended that insurers’ use of genetic test results in underwriting should be prohibited. In 2019, the FSC introduced an industry self-regulated moratorium on the use of genetic test results. (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  7.  49
    How Should We Deal with Misattributed Paternity? A Survey of Lay Public Attitudes.Georgia Lowe, Jonathan Pugh, Guy Kahane, Louise Corben, Sharon Lewis, Martin Delatycki & Julian Savulescu - 2017 - Ajob Empirical Bioethics 8 (4):234-242.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  8. Predictive Genetic Testing for Neurodegenerative Conditions: How Should Conflicting Interests Within Families Be Managed?Zornitza Stark, Jane Wallace, Lynn Gillam, Matthew Burgess & Martin B. Delatycki - 2016 - Journal of Medical Ethics 42 (10):640-642.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  9.  5
    Genetic Discrimination in Life Insurance: A Human Rights Issue.Jane Tiller & Martin B. Delatycki - 2021 - Journal of Medical Ethics 47 (7):484-485.
    In this issue of Journal of Medical Ethics, Pugh1 offers a pluralist justice-based argument in support of the spirit, if not the precise letter, of the UK approach to the use of genetic test results to underwrite life insurance. We agree with Dr Pugh’s general contention that there is ethical and philosophical support for curtailment of insurers’ access to, and use of, applicants’ GTR in underwriting. However, we disagree with the contention that broad revisionary implications of certain theories of justice (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark